167 related articles for article (PubMed ID: 31127068)
1. Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease.
Wood JH; Guo J; Morrell NW; Li W
Biochem Soc Trans; 2019 Jun; 47(3):779-791. PubMed ID: 31127068
[TBL] [Abstract][Full Text] [Related]
2. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
[TBL] [Abstract][Full Text] [Related]
6. BMP9 and BMP10: Two close vascular quiescence partners that stand out.
Desroches-Castan A; Tillet E; Bouvard C; Bailly S
Dev Dyn; 2022 Jan; 251(1):178-197. PubMed ID: 34240497
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
8. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
9. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
10. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
[TBL] [Abstract][Full Text] [Related]
11. BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.
Wang L; Rice M; Swist S; Kubin T; Wu F; Wang S; Kraut S; Weissmann N; Böttger T; Wheeler M; Schneider A; Braun T
Circulation; 2021 Apr; 143(14):1394-1410. PubMed ID: 33334130
[TBL] [Abstract][Full Text] [Related]
12. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong Z; Guo J; Glen RC; Morrell NW; Li W
Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
[TBL] [Abstract][Full Text] [Related]
13. Regulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.
Wei Z; Salmon RM; Upton PD; Morrell NW; Li W
J Biol Chem; 2014 Nov; 289(45):31150-9. PubMed ID: 25237187
[TBL] [Abstract][Full Text] [Related]
14. Characterization of
Hodgson J; Swietlik EM; Salmon RM; Hadinnapola C; Nikolic I; Wharton J; Guo J; Liley J; Haimel M; Bleda M; Southgate L; Machado RD; Martin JM; Treacy CM; Yates K; Daugherty LC; Shamardina O; Whitehorn D; Holden S; Bogaard HJ; Church C; Coghlan G; Condliffe R; Corris PA; Danesino C; Eyries M; Gall H; Ghio S; Ghofrani HA; Gibbs JSR; Girerd B; Houweling AC; Howard L; Humbert M; Kiely DG; Kovacs G; Lawrie A; MacKenzie Ross RV; Moledina S; Montani D; Olschewski A; Olschewski H; Ouwehand WH; Peacock AJ; Pepke-Zaba J; Prokopenko I; Rhodes CJ; Scelsi L; Seeger W; Soubrier F; Suntharalingam J; Toshner MR; Trembath RC; Vonk Noordegraaf A; Wort SJ; Wilkins MR; Yu PB; Li W; Gräf S; Upton PD; Morrell NW
Am J Respir Crit Care Med; 2020 Mar; 201(5):575-585. PubMed ID: 31661308
[No Abstract] [Full Text] [Related]
15. Role of soluble endoglin in BMP9 signaling.
Lawera A; Tong Z; Thorikay M; Redgrave RE; Cai J; van Dinther M; Morrell NW; Afink GB; Charnock-Jones DS; Arthur HM; Ten Dijke P; Li W
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17800-17808. PubMed ID: 31431534
[TBL] [Abstract][Full Text] [Related]
16. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
[TBL] [Abstract][Full Text] [Related]
17. Endothelial protective factors BMP9 and BMP10 inhibit CCL2 release by human vascular endothelial cells.
Upton PD; Park JES; De Souza PM; Davies RJ; Griffiths MJD; Wort SJ; Morrell NW
J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32576665
[TBL] [Abstract][Full Text] [Related]
18. Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.
van Meeteren LA; Thorikay M; Bergqvist S; Pardali E; Stampino CG; Hu-Lowe D; Goumans MJ; ten Dijke P
J Biol Chem; 2012 May; 287(22):18551-61. PubMed ID: 22493445
[TBL] [Abstract][Full Text] [Related]
19. Endothelial
Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
[TBL] [Abstract][Full Text] [Related]
20. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD
EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
